Why does the cardiovascular system need the endocrine system

Curr Med Chem ;—8. The cardiovascular system in growth hormone excess and growth hormone deficiency. J Endocrinol Invest ;—9. Growth hormone and the cardiovascular system. Cardiol Rev ;— Adipokines and the cardiovascular system: mechanisms mediating health and disease. Can J Physiol Pharmacol ;— Abel ED, Sweeney G. Modulation of the cardiovascular system by leptin. Biochimie ;— Protective role of adiponectin in cardiovascular disease. Curr Med Chem ;— Circadian rhythms and cardiovascular health.

Sleep Med Rev ;— Shaw E, Tofler GH. Circadian rhythm and cardiovascular disease. Curr Atheroscler Rep ;— Your documents are now available to view. Confirm Cancel. Victoria Cachofeiro and Vicente Lahera. Cite this. You currently have no access to view or download this content. Advertisement Hide. Endocrine System and Cardiovascular Disease. Chapter First Online: 11 February This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in to check access. Pathophysiology and implications for management. Klein I, Danzi S Thyroid disease and the heart. Biondi B, Klein I Hypothyroidism as a risk factor for cardiovascular disease. Qari A Thyroid hormone profile in patients with acute coronary syndrome. Barbesino G Drugs affecting thyroid function. Klein I , Ojamaa K Thyroid hormone and thecardiovascular system. N Engl J Med : — Duntas LH Thyroid disease and lipids.

Thyroid 12 : — Arterioscler Thromb Vasc Biol 21 : — Cell : — Curr Opin Nephrol Hypertens 12 : — Trends Endocrinol Metab 12 : — Trends Cardiovasc Med 12 : — Curr Hypertens Rep 2 : — J Clin Hypertens Greenwich 4 : 62 — Curr Opin Nephrol Hypertens 10 : 99 — McFarlane SI , Sowers JR Cardiovascularendocrinology 1: aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease.

J Clin Endocrinol Metab 88 : — Pharmacotherapy 23 : — J Renin Angiotensin Aldosterone Syst 3 : — Izzo JL , Moser M Clinical impact ofrenin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. J Clin Hypertens Greenwich 4 Suppl 2 : 11 — Trends Pharmacol Sci 22 : — Krebs LJ , Arnold A Molecular basis ofhyperparathyroidism and potential targets for drug development.

An analysis of the National Cancer Registry Data. Acta Med Scand : — Mayo Clin Proc 58 : — Mayo Clin Proc 77 : — Textor SC Epidemiology and clinicalpresentation. Semin Nephrol 20 : — Reaven G Metabolic syndrome: pathophysiologyand implications for management of cardiovascular disease.

Circulation : — Pi-Sunyer X A clinical view of the obesityproblem. Annu Rev Med 44 : — JAMA : — Am J Cardiol 81 : 7 B—12B. Libby P , Aikawa M Mechanisms of plaquestabilization with statins. Am J Cardiol 91 Suppl 4A : 4 — 8.

Ann Intern Med : — Sawin CT Subclinical hyperthyroidism andatrial fibrillation. Arch Intern Med : — J Clin Endocrinol Metab 86 : — Endocrinol Metab Clin North Am 30 : — J Hypertens 20 : — Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.

Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents I. Endocrine Signals and the Cardiovascular System. Nuclear Receptors. Second Messenger Signaling Systems. Clinical Endocrinology. Hormone Replacement Therapy. Cardiovascular Endocrinology: Introduction. Baxter , John D. Baxter, M. Oxford Academic. William F. Paul Webb. Cite Cite John D. Select Format Select format. Permissions Icon Permissions.

Introduction II. Nuclear Receptors IV. Second Messenger Signaling Systems V. Hypertension B. Metabolic syndrome C. Obesity D. Dyslipidemia E. Thyroid disease F. Diabetes and cardiovascular disease VI.

Hormone Replacement Therapy I. Endocrine Signals and the Cardiovascular System The cardiovascular system responds to multiple endocrine signals, and there are strong parallels between the mechanisms of endocrine and other types of signals that influence the function of the cardiovascular system nutritional signals, nerve inputs, etc.

Nuclear Receptors The nuclear receptors are a large family of conditional transcription factors that consist of single polypeptide chains with separable domains that mediate ligand binding, transactivation and transrepression, DNA binding, and interactions with other coregulatory proteins 1 — 3. Open in new tab Download slide. Open in new tab. Google Scholar Crossref. Search ADS. The coregulatorexchange in transcriptional functions of nuclear receptors.

Google Scholar PubMed. From ligand toresponse: generating diversity in nuclear receptor coregulator function. Gene regulatorymechanisms governing energy metabolism during cardiac hypertrophic growth.

A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.

Hyperaldosteronism among black and white subjects with resistant hypertension. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. The RORnuclear orphan receptor subfamily: critical regulators of multiple biological processes. Angiotensin type 2receptors: potential importance in the regulation of blood pressure.

Cardiovascularendocrinology 1: aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease. Clinical impact ofrenin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. Molecular basis ofhyperparathyroidism and potential targets for drug development. Pheochromocytoma inSweden — Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Metabolic syndrome: pathophysiologyand implications for management of cardiovascular disease.

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. TSH-controlled l -thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial Basel Thyroid Study. Issue Section:. Download all slides. View Metrics. Email alerts Article activity alert. Advance article alerts. New issue alert. Receive exclusive offers and updates from Oxford Academic. Cardiovascular Biology of the Incretin System.

In Memoriam: John D. Related articles in Web of Science Google Scholar. Frequency of synchronous malignant liver lesions initially detected by ultrasound in patients with newly diagnosed underlying non-hematologic malignant disease: a retrospective study in patients.